Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
Jennifer N. Brudno(National Institutes of Health), Norris Lam(National Institutes of Health), Danielle Vanasse(National Institutes of Health), Yueh-wei Shen(Kite (United States)), Jeremy J. Rose(National Institutes of Health), John M. Rossi(Kite (United States)), Allen Xue(Kite (United States)), Adrian Bot(Kite (United States)), Nathalie Scholler(Kite (United States)), Lekha Mikkilineni, Mark Roschewski(Center for Cancer Research), Robert M. Dean(Cleveland Clinic), Raúl E. Cachau(Frederick National Laboratory for Cancer Research), Philippe Youkharibache(National Institutes of Health), Rashmika Patel(Office of the Director), Brenna Hansen(National Institutes of Health), David F. Stroncek, Steven A. Rosenberg(Center for Cancer Research), Ronald E. Gress(National Institutes of Health), James N. Kochenderfer(National Institutes of Health)
Cited by 312Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis